Abstract
Lysine specific demethylase 1 (LSD1) plays a key role in the regulation of gene expression by removing the methyl groups from methylated Lys4 of histone H3 (H3K4). Here we report the identification of the first small-molecule LSD1-selective inhibitors. These inhibitors show in vivo H3K4-methylating activity and antiproliferative activity and should be useful as lead structures for anticancer drugs and as tools for studying the biological roles of LSD1.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Catalytic Domain
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Crystallography, X-Ray
-
Drug Design
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / metabolism
-
Enzyme Inhibitors / pharmacology*
-
Histone Demethylases / antagonists & inhibitors*
-
Histone Demethylases / chemistry
-
Histones / metabolism
-
Humans
-
Models, Molecular
-
Substrate Specificity
Substances
-
Enzyme Inhibitors
-
Histones
-
Histone Demethylases
-
KDM1A protein, human